drugset
drugset / Trial / NCT02345031

Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss

NCT02345031 ↗

Phase 2 Completed 78 enrolled Autifony Therapeutics Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to demonstrate that the investigational drug AUT00063 is effective and safe in the treatment of age-related hearing loss.

Timeline

Start
2015-01
Primary completion
2016-05
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator AUT00063 Unknown 600 mg Oral

Indications

presbycusis